1.Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Thanh N. NGUYEN ; Muhammad M. QURESHI ; Piers KLEIN ; Hiroshi YAMAGAMI ; Mohamad ABDALKADER ; Robert MIKULIK ; Anvitha SATHYA ; Ossama Yassin MANSOUR ; Anna CZLONKOWSKA ; Hannah LO ; Thalia S. FIELD ; Andreas CHARIDIMOU ; Soma BANERJEE ; Shadi YAGHI ; James E. SIEGLER ; Petra SEDOVA ; Joseph KWAN ; Diana Aguiar DE SOUSA ; Jelle DEMEESTERE ; Violiza INOA ; Setareh Salehi OMRAN ; Liqun ZHANG ; Patrik MICHEL ; Davide STRAMBO ; João Pedro MARTO ; Raul G. NOGUEIRA ; ; Espen Saxhaug KRISTOFFERSEN ; Georgios TSIVGOULIS ; Virginia Pujol LEREIS ; Alice MA ; Christian ENZINGER ; Thomas GATTRINGER ; Aminur RAHMAN ; Thomas BONNET ; Noémie LIGOT ; Sylvie DE RAEDT ; Robin LEMMENS ; Peter VANACKER ; Fenne VANDERVORST ; Adriana Bastos CONFORTO ; Raquel C.T. HIDALGO ; Daissy Liliana MORA CUERVO ; Luciana DE OLIVEIRA NEVES ; Isabelle LAMEIRINHAS DA SILVA ; Rodrigo Targa MARTÍNS ; Letícia C. REBELLO ; Igor Bessa SANTIAGO ; Teodora SADELAROVA ; Rosen KALPACHKI ; Filip ALEXIEV ; Elena Adela CORA ; Michael E. KELLY ; Lissa PEELING ; Aleksandra PIKULA ; Hui-Sheng CHEN ; Yimin CHEN ; Shuiquan YANG ; Marina ROJE BEDEKOVIC ; Martin ČABAL ; Dusan TENORA ; Petr FIBRICH ; Pavel DUŠEK ; Helena HLAVÁČOVÁ ; Emanuela HRABANOVSKA ; Lubomír JURÁK ; Jana KADLČÍKOVÁ ; Igor KARPOWICZ ; Lukáš KLEČKA ; Martin KOVÁŘ ; Jiří NEUMANN ; Hana PALOUŠKOVÁ ; Martin REISER ; Vladimir ROHAN ; Libor ŠIMŮNEK ; Ondreij SKODA ; Miroslav ŠKORŇA ; Martin ŠRÁMEK ; Nicolas DRENCK ; Khalid SOBH ; Emilie LESAINE ; Candice SABBEN ; Peggy REINER ; Francois ROUANET ; Daniel STRBIAN ; Stefan BOSKAMP ; Joshua MBROH ; Simon NAGEL ; Michael ROSENKRANZ ; Sven POLI ; Götz THOMALLA ; Theodoros KARAPANAYIOTIDES ; Ioanna KOUTROULOU ; Odysseas KARGIOTIS ; Lina PALAIODIMOU ; José Dominguo BARRIENTOS GUERRA ; Vikram HUDED ; Shashank NAGENDRA ; Chintan PRAJAPATI ; P.N. SYLAJA ; Achmad Firdaus SANI ; Abdoreza GHOREISHI ; Mehdi FARHOUDI ; Elyar SADEGHI HOKMABADI ; Mazyar HASHEMILAR ; Sergiu Ionut SABETAY ; Fadi RAHAL ; Maurizio ACAMPA ; Alessandro ADAMI ; Marco LONGONI ; Raffaele ORNELLO ; Leonardo RENIERI ; Michele ROMOLI ; Simona SACCO ; Andrea SALMAGGI ; Davide SANGALLI ; Andrea ZINI ; Kenichiro SAKAI ; Hiroki FUKUDA ; Kyohei FUJITA ; Hirotoshi IMAMURA ; Miyake KOSUKE ; Manabu SAKAGUCHI ; Kazutaka SONODA ; Yuji MATSUMARU ; Nobuyuki OHARA ; Seigo SHINDO ; Yohei TAKENOBU ; Takeshi YOSHIMOTO ; Kazunori TOYODA ; Takeshi UWATOKO ; Nobuyuki SAKAI ; Nobuaki YAMAMOTO ; Ryoo YAMAMOTO ; Yukako YAZAWA ; Yuri SUGIURA ; Jang-Hyun BAEK ; Si Baek LEE ; Kwon-Duk SEO ; Sung-Il SOHN ; Jin Soo LEE ; Anita Ante ARSOVSKA ; Chan Yong CHIEH ; Wan Asyraf WAN ZAIDI ; Wan Nur Nafisah WAN YAHYA ; Fernando GONGORA-RIVERA ; Manuel MARTINEZ-MARINO ; Adrian INFANTE-VALENZUELA ; Diederik DIPPEL ; Dianne H.K. VAN DAM-NOLEN ; Teddy Y. WU ; Martin PUNTER ; Tajudeen Temitayo ADEBAYO ; Abiodun H. BELLO ; Taofiki Ajao SUNMONU ; Kolawole Wasiu WAHAB ; Antje SUNDSETH ; Amal M. AL HASHMI ; Saima AHMAD ; Umair RASHID ; Liliana RODRIGUEZ-KADOTA ; Miguel Ángel VENCES ; Patrick Matic YALUNG ; Jon Stewart Hao DY ; Waldemar BROLA ; Aleksander DĘBIEC ; Malgorzata DOROBEK ; Michal Adam KARLINSKI ; Beata M. LABUZ-ROSZAK ; Anetta LASEK-BAL ; Halina SIENKIEWICZ-JAROSZ ; Jacek STASZEWSKI ; Piotr SOBOLEWSKI ; Marcin WIĄCEK ; Justyna ZIELINSKA-TUREK ; André Pinho ARAÚJO ; Mariana ROCHA ; Pedro CASTRO ; Patricia FERREIRA ; Ana Paiva NUNES ; Luísa FONSECA ; Teresa PINHO E MELO ; Miguel RODRIGUES ; M Luis SILVA ; Bogdan CIOPLEIAS ; Adela DIMITRIADE ; Cristian FALUP-PECURARIU ; May Adel HAMID ; Narayanaswamy VENKETASUBRAMANIAN ; Georgi KRASTEV ; Jozef HARING ; Oscar AYO-MARTIN ; Francisco HERNANDEZ-FERNANDEZ ; Jordi BLASCO ; Alejandro RODRÍGUEZ-VÁZQUEZ ; Antonio CRUZ-CULEBRAS ; Francisco MONICHE ; Joan MONTANER ; Soledad PEREZ-SANCHEZ ; María Jesús GARCÍA SÁNCHEZ ; Marta GUILLÁN RODRÍGUEZ ; Gianmarco BERNAVA ; Manuel BOLOGNESE ; Emmanuel CARRERA ; Anchalee CHUROJANA ; Ozlem AYKAC ; Atilla Özcan ÖZDEMIR ; Arsida BAJRAMI ; Songul SENADIM ; Syed I. HUSSAIN ; Seby JOHN ; Kailash KRISHNAN ; Robert LENTHALL ; Kaiz S. ASIF ; Kristine BELOW ; Jose BILLER ; Michael CHEN ; Alex CHEBL ; Marco COLASURDO ; Alexandra CZAP ; Adam H. DE HAVENON ; Sushrut DHARMADHIKARI ; Clifford J. ESKEY ; Mudassir FAROOQUI ; Steven K. FESKE ; Nitin GOYAL ; Kasey B. GRIMMETT ; Amy K. GUZIK ; Diogo C. HAUSSEN ; Majesta HOVINGH ; Dinesh JILLELA ; Peter T. KAN ; Rakesh KHATRI ; Naim N. KHOURY ; Nicole L. KILEY ; Murali K. KOLIKONDA ; Stephanie LARA ; Grace LI ; Italo LINFANTE ; Aaron I. LOOCHTAN ; Carlos D. LOPEZ ; Sarah LYCAN ; Shailesh S. MALE ; Fadi NAHAB ; Laith MAALI ; Hesham E. MASOUD ; Jiangyong MIN ; Santiago ORGETA-GUTIERREZ ; Ghada A. MOHAMED ; Mahmoud MOHAMMADEN ; Krishna NALLEBALLE ; Yazan RADAIDEH ; Pankajavalli RAMAKRISHNAN ; Bliss RAYO-TARANTO ; Diana M. ROJAS-SOTO ; Sean RULAND ; Alexis N. SIMPKINS ; Sunil A. SHETH ; Amy K. STAROSCIAK ; Nicholas E. TARLOV ; Robert A. TAYLOR ; Barbara VOETSCH ; Linda ZHANG ; Hai Quang DUONG ; Viet-Phuong DAO ; Huynh Vu LE ; Thong Nhu PHAM ; Mai Duy TON ; Anh Duc TRAN ; Osama O. ZAIDAT ; Paolo MACHI ; Elisabeth DIRREN ; Claudio RODRÍGUEZ FERNÁNDEZ ; Jorge ESCARTÍN LÓPEZ ; Jose Carlos FERNÁNDEZ FERRO ; Niloofar MOHAMMADZADEH ; Neil C. SURYADEVARA, MD ; Beatriz DE LA CRUZ FERNÁNDEZ ; Filipe BESSA ; Nina JANCAR ; Megan BRADY ; Dawn SCOZZARI
Journal of Stroke 2022;24(2):256-265
		                        		
		                        			 Background:
		                        			and Purpose Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. 
		                        		
		                        			Methods:
		                        			We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). 
		                        		
		                        			Results:
		                        			There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths.  
		                        		
		                        			Conclusions
		                        			During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT. 
		                        		
		                        		
		                        		
		                        	
2.Management of isolated mandibular body fractures in adults
José ; Florencio F. Lapeñ ; a, Jr. ; Joselito F. David ; Ann Nuelli B. Acluba - Pauig ; Jehan Grace B. Maglaya ; Enrico Micael G. Donato ; Francis V. Roasa ; Philip B. Fullante ; Jose Rico A. Antonio ; Ryan Neil C. Adan ; Arsenio L. Pascual III ; Jennifer M. de Silva- Leonardo ; Mark Anthony T. Gomez ; Isaac Cesar S. De Guzman ; Veronica Jane B. Yanga ; Irlan C. Altura ; Dann Joel C. Caro ; Karen Mae A. Ty ; Elmo . R. Lago Jr ; Joy Celyn G. Ignacio ; Antonio Mario L. de Castro ; Policarpio B. Joves Jr. ; Alejandro V. Pineda Jr. ; Edgardo Jose B. Tan ; Tita Y. Cruz ; Eliezer B. Blanes ; Mario E. Esquillo ; Emily Rose M. Dizon ; Joman Q. Laxamana ; Fernando T. Aninang ; Ma. Carmela Cecilia G. Lapeñ ; a
Philippine Journal of Otolaryngology Head and Neck Surgery 2021;36(Supplements):1-43
		                        		
		                        			Objective:
		                        			The  mandible  is  the  most  common  fractured  craniofacial  bone  of  all  craniofacial  fractures  in  the  Philippines,  with  the  mandibular  body  as  the  most  involved  segment  of  all  mandibular  fractures.  To  the  best  of  our  knowledge,  there  are  no  existing  guidelines  for  the  diagnosis  and  management of mandibular body fractures in particular. General guidelines include the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAOHNSF) Resident Manual of Trauma to the Face, Head, and Neck chapter on Mandibular Trauma, the American Association of Oral and Maxillofacial Surgeons (AAOMS) Clinical Practice Guidelines for Oral and Maxillofacial Surgery  section  on  the  Mandibular  Angle,  Body,  and  Ramus,  and  a  2013  Cochrane  Systematic  Review  on  interventions  for  the  management  of  mandibular  fractures.  On  the  other  hand,  a  very  specific  Clinical  Practice  Guideline  on  the  Management  of  Unilateral  Condylar  Fracture  of  the  Mandible  was  published  by  the  Ministry  of  Health  Malaysia  in  2005.  Addressing  the  prevalence of mandibular body fractures, and dearth of specific guidelines for its diagnosis and management, this clinical practice guideline focuses on the management of isolated mandibular body fractures in adults.
		                        		
		                        			Purpose:
		                        			This  guideline  is  meant  for  all  clinicians  (otolaryngologists  –  head  and  neck  surgeons,  as  well  as  primary  care  and  specialist  physicians,  nurses  and  nurse  practitioners,  midwives  and  community  health  workers,  dentists,  and  emergency  first-responders)  who  may  provide  care  to  adults  aged  18  years  and  above  that  may  present  with  an  acute  history  and  physical  and/or  laboratory  examination  findings  that  may  lead  to  a  diagnosis  of  isolated  mandibular  body  fracture and its subsequent medical and surgical management, including health promotion and disease prevention. It  is  applicable  in  any  setting  (including  urban  and  rural  primary-care,  community  centers,  treatment  units,  hospital  emergency  rooms,  operating  rooms)  in  which  adults  with  isolated  mandibular body fractures would be identified, diagnosed, or managed. Outcomes   are   functional   resolution   of   isolated   mandibular   body   fractures;   achieving   premorbid form; avoiding use of context-inappropriate diagnostics and therapeutics; minimizing use  of  ineffective  interventions;  avoiding  co-morbid  infections,  conditions,  complications  and  adverse  events;  minimizing  cost;  maximizing  health-related  quality  of  life  of  individuals  with  isolated mandibular body fracture; increasing patient satisfaction; and preventing recurrence in patients and occurrence in others.
		                        		
		                        			Action Statements
		                        			The  guideline  development  group  made  strong  recommendationsfor the following key action statements: (6) pain management- clinicians should  routinely  evaluate  pain  in  patients  with  isolated  mandibular  body  fractures  using  a  numerical  rating  scale  (NRS)  or  visual  analog  scale  (VAS);  analgesics  should  be  routinely  offered  to  patients  with  a  numerical  rating  pain  scale  score  or  VAS  of  at  least  4/10  (paracetamol  and  a  mild  opioid  with  or  without  an  adjuvant  analgesic)  until  the  numerical rating pain scale score or VAS is 3/10 at most; (7) antibiotics- prophylactic antibiotics should be given to adult patients with isolated mandibular body fractures with concomitant mucosal or skin opening with or without direct visualization of bone fragments; penicillin is the drug of choice while clindamycin may be used as an alternative; and (14) prevention- clinicians should advocate for compliance with road traffic safety laws (speed limit, anti-drunk driving, seatbelt and helmet use) for the prevention of motor vehicle, cycling and pedestrian accidents and maxillofacial injuries.The   guideline   development   group   made   recommendations   for   the  following  key  action  statements:  (1)  history,  clinical  presentation,  and  diagnosis  -  clinicians  should  consider  a  presumptive  diagnosis  of  mandibular  fracture  in  adults  presenting  with  a  history  of  traumatic  injury  to  the  jaw  plus  a  positive  tongue  blade  test,  and  any  of  the  following: malocclusion, trismus, tenderness on jaw closure and broken tooth; (2) panoramic x-ray - clinicians may request for panoramic x-ray as  the  initial  imaging  tool  in  evaluating  patients  with  a  presumptive  clinical diagnosis; (3) radiographs - where panoramic radiography is not available,  clinicians  may  recommend  plain  mandibular  radiography;  (4)  computed  tomography  -  if  available,  non-contrast  facial  CT  Scan  may be obtained; (5) immobilization - fractures should be temporarily immobilized/splinted  with  a  figure-of-eight  bandage  until  definitive  surgical  management  can  be  performed  or  while  initiating  transport  during emergency situations; (8) anesthesia - nasotracheal intubation is the preferred route of anesthesia; in the presence of contraindications, submental    intubation    or    tracheostomy    may    be    performed;    (9)    observation - with a soft diet may serve as management for favorable isolated nondisplaced and nonmobile mandibular body fractures with unchanged  pre  -  traumatic  occlusion;  (10)  closed  reduction  -  with  immobilization  by  maxillomandibular  fixation  for  4-6  weeks  may  be  considered   for   minimally   displaced   favorable   isolated   mandibular   body  fractures  with  stable  dentition,  good  nutrition  and  willingness  to comply with post-procedure care that may affect oral hygiene, diet modifications, appearance, oral health and functional concerns (eating, swallowing   and   speech);   (11)   open   reduction   with   transosseous   wiring  -  with  MMF  is  an  option  for  isolated  displaced  unfavorable and  unstable  mandibular  body  fracture  patients  who  cannot  afford  or  avail  of  titanium  plates;  (12)  open  reduction  with  titanium  plates  -  ORIF using titanium plates and screws should be performed in isolated displaced  unfavorable  and  unstable  mandibular  body  fracture;  (13)  maxillomandibular fixation - intraoperative MMF may not be routinely needed  prior  to  reduction  and  internal  fixation;  and  (15)  promotion  -  clinicians should play a positive role in the prevention of interpersonal and collective violence as well as the settings in which violence occurs in order to avoid injuries in general and mandibular fractures in particular.
		                        		
		                        		
		                        		
		                        			Mandibular Fractures
		                        			;
		                        		
		                        			 Jaw Fractures
		                        			;
		                        		
		                        			 Classification
		                        			;
		                        		
		                        			 History
		                        			;
		                        		
		                        			 Diagnosis
		                        			;
		                        		
		                        			 Diagnostic Imaging
		                        			;
		                        		
		                        			 Therapeutics
		                        			;
		                        		
		                        			 Diet Therapy
		                        			;
		                        		
		                        			 Drug Therapy
		                        			;
		                        		
		                        			 Rehabilitation
		                        			;
		                        		
		                        			 General Surgery
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail